Cogstate Past Earnings Performance
Past criteria checks 4/6
Cogstate has been growing earnings at an average annual rate of 50%, while the Healthcare Services industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 15.9% per year. Cogstate's return on equity is 14.5%, and it has net margins of 13.4%.
Key information
50.0%
Earnings growth rate
51.7%
EPS growth rate
Healthcare Services Industry Growth | 42.6% |
Revenue growth rate | 15.9% |
Return on equity | 14.5% |
Net Margin | 13.4% |
Next Earnings Update | 22 Aug 2024 |
Recent past performance updates
Recent updates
If EPS Growth Is Important To You, Cogstate (ASX:CGS) Presents An Opportunity
May 13The Price Is Right For Cogstate Limited (ASX:CGS)
Jan 17Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?
Jul 26Returns Are Gaining Momentum At Cogstate (ASX:CGS)
Apr 14Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%
Mar 23Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts
Mar 02Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate
Jan 13Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%
Oct 04Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?
Sep 28Returns On Capital Are A Standout For Cogstate (ASX:CGS)
Sep 02We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease
Jun 30Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital
Mar 22We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation
Oct 20Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital
Jul 23Is Cogstate (ASX:CGS) Using Too Much Debt?
Apr 29What Can The Trends At Cogstate (ASX:CGS) Tell Us About Their Returns?
Mar 14Here's What Cogstate Limited's (ASX:CGS) Shareholder Ownership Structure Looks Like
Feb 21How Much Is Cogstate's (ASX:CGS) CEO Getting Paid?
Jan 17Can You Imagine How Jubilant Cogstate's (ASX:CGS) Shareholders Feel About Its 214% Share Price Gain?
Dec 05Revenue & Expenses Breakdown
How Cogstate makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 41 | 6 | 16 | 0 |
30 Sep 23 | 41 | 5 | 16 | 0 |
30 Jun 23 | 40 | 4 | 16 | 0 |
31 Mar 23 | 41 | 4 | 15 | 0 |
31 Dec 22 | 41 | 3 | 14 | 0 |
30 Sep 22 | 43 | 6 | 14 | 0 |
30 Jun 22 | 45 | 8 | 13 | 0 |
31 Mar 22 | 43 | 9 | 13 | 0 |
31 Dec 21 | 42 | 10 | 13 | 0 |
30 Sep 21 | 37 | 7 | 12 | 0 |
30 Jun 21 | 33 | 5 | 12 | 0 |
31 Mar 21 | 30 | 3 | 11 | 0 |
31 Dec 20 | 28 | 0 | 10 | 0 |
30 Sep 20 | 25 | -1 | 10 | 0 |
30 Jun 20 | 23 | -2 | 10 | 0 |
31 Mar 20 | 21 | -3 | 10 | 0 |
31 Dec 19 | 19 | -3 | 10 | 0 |
30 Sep 19 | 21 | -3 | 11 | 0 |
30 Jun 19 | 22 | -2 | 12 | 0 |
31 Mar 19 | 24 | -2 | 14 | 0 |
31 Dec 18 | 27 | -1 | 15 | 0 |
30 Sep 18 | 28 | -1 | 15 | 0 |
30 Jun 18 | 29 | -1 | 15 | 0 |
31 Mar 18 | 27 | -2 | 15 | 0 |
31 Dec 17 | 26 | -3 | 14 | 0 |
30 Sep 17 | 26 | -2 | 14 | 0 |
30 Jun 17 | 26 | -1 | 14 | 0 |
31 Mar 17 | 26 | 0 | 13 | 0 |
31 Dec 16 | 24 | 1 | 13 | 0 |
30 Sep 16 | 23 | 1 | 12 | 0 |
30 Jun 16 | 20 | 2 | 11 | 0 |
31 Mar 16 | 19 | 1 | 10 | 0 |
31 Dec 15 | 17 | 0 | 9 | 0 |
30 Sep 15 | 14 | -2 | 9 | 0 |
30 Jun 15 | 12 | -4 | 9 | 0 |
31 Mar 15 | 11 | -3 | 8 | 0 |
31 Dec 14 | 10 | -3 | 8 | 0 |
30 Sep 14 | 10 | -3 | 9 | 0 |
30 Jun 14 | 11 | -4 | 9 | 0 |
31 Mar 14 | 11 | -4 | 9 | 0 |
31 Dec 13 | 11 | -4 | 9 | 0 |
30 Sep 13 | 11 | -3 | 9 | 0 |
30 Jun 13 | 11 | -2 | 8 | 0 |
Quality Earnings: CGS has a high level of non-cash earnings.
Growing Profit Margin: CGS's current net profit margins (13.4%) are higher than last year (8.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CGS has become profitable over the past 5 years, growing earnings by 50% per year.
Accelerating Growth: CGS's earnings growth over the past year (57.6%) exceeds its 5-year average (50% per year).
Earnings vs Industry: CGS earnings growth over the past year (57.6%) exceeded the Healthcare Services industry 8%.
Return on Equity
High ROE: CGS's Return on Equity (14.5%) is considered low.